Oral Semaglutide (Rybelsus): A New Standard in Type 2 Diabetes TreatmentApril 21, 2026 Oral semaglutide, marketed as Rybelsus, represents a significant advancement in the treatment of type 2 diabetes. As the first GLP-1…
